Q2 2024 Holdings
Filed 2024-08-09 | 82 holdings | $1.9B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Marinus Pharmaceuticals Inc(MRNS*)Call | COM | 56854Q200 | $122.5K | 104,700 | 0.0% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $350.1K | 8,915 | 0.0% |
| Kyverna Therapeutics Inc(KYTX) | COM | 501976104 | $358.9K | 47,850 | 0.0% |
| Pulmonx Corp(LUNG) | COM | 745848101 | $382.0K | 60,246 | 0.0% |
| PDS Biotechnology Corp(PDSB) | COM | 70465T107 | $417.9K | 142,635 | 0.0% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $552.3K | 60,692 | 0.0% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $569.4K | 299,691 | 0.0% |
| Amylyx Pharmaceuticals Inc(AMLX)Put | COM | 03237H101 | $570.0K | 300,000 | 0.0% |
| Savara Inc(SVRA)Put | COM | 805111101 | $604.5K | 150,000 | 0.0% |
| Ikena Oncology Inc | COM | 45175G108 | $631.3K | 382,616 | 0.0% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $875.2K | 21,425 | 0.0% |
| Immatics N.v | W EXP 07/01/2025 | N44445117 | $932.9K | 348,731 | 0.0% |
| LivaNova PLC(LIVN) | SHS | G5509L101 | $1.1M | 20,602 | 0.1% |
| Zimmer Biomet Holdings Inc(ZBH) | COM | 98956P102 | $1.2M | 10,630 | 0.1% |
| Perspective Therapeutics Inc(CATX) | COM | 46489V302 | $1.3M | 132,089 | 0.1% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $1.3M | 29,256 | 0.1% |
| Inspire Med Sys Inc(INSP) | COM | 457730109 | $1.3M | 10,000 | 0.1% |
| Bolt Biotherapeutics Inc(BOLT1EUR) | COM | 097702104 | $2.1M | 2,754,437 | 0.1% |
| Masimo Corp(MASI) | COM | 574795100 | $2.5M | 20,161 | 0.1% |
| Teleflex Incorporated(TFX) | COM | 879369106 | $2.9M | 13,649 | 0.1% |
| Avantor Inc(AVTR) | COM | 05352A100 | $3.0M | 141,045 | 0.2% |
| Baxter Intl Inc(BAX) | COM | 071813109 | $3.9M | 117,769 | 0.2% |
| Phibro Animal Health Corp(PAHC) | CL A COM | 71742Q106 | $4.0M | 237,009 | 0.2% |
| Erasca Inc(ERAS) | COM | 29479A108 | $4.0M | 1,699,528 | 0.2% |
| Nextcure Inc | COM | 65343E108 | $4.2M | 2,671,856 | 0.2% |
| Marinus Pharmaceuticals Inc(MRNS*) | COM | 56854Q200 | $4.9M | 4,151,576 | 0.3% |
| 4D Molecular Therapeutics Inc(FDMT) | COM | 35104E100 | $5.7M | 271,155 | 0.3% |
| Aerovate Therapeutics Inc | COM | 008064107 | $6.2M | 3,758,686 | 0.3% |
| Waters Corp(WAT) | COM | 941848103 | $6.3M | 21,804 | 0.3% |
| Achieve Life Sciences Inc(ACHV) | COM | 004468500 | $6.5M | 1,388,372 | 0.3% |
| Inhibrx Biosciences Inc(INBX) | COM | 45720N103 | $6.6M | 463,315 | 0.3% |
| Dexcom Inc(DXCM) | COM | 252131107 | $7.0M | 61,494 | 0.4% |
| Inari Med Inc(NARIUSD) | COM | 45332Y109 | $7.5M | 155,838 | 0.4% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $7.7M | 181,828 | 0.4% |
| Immunome Inc(IMNM) | COM | 45257U108 | $7.9M | 655,680 | 0.4% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $8.6M | 475,691 | 0.4% |
| PepGen Inc(PEPG) | COM | 713317105 | $9.0M | 561,128 | 0.5% |
| Cabaletta Bio Inc(CABA) | COM | 12674W109 | $9.1M | 1,220,400 | 0.5% |
| Immatics N.v(IMTX) | SHS | N44445109 | $9.3M | 796,704 | 0.5% |
| Axonics Inc(AXNX*) | COM | 05465P101 | $10.1M | 150,490 | 0.5% |
| Pharvaris N V(PHVS) | COM | N69605108 | $11.3M | 601,534 | 0.6% |
| Alnylam Pharmaceuticals Inc(ALNY)Call | COM | 02043Q107 | $12.2M | 50,000 | 0.6% |
| Insulet Corp(PODD) | COM | 45784P101 | $12.3M | 60,967 | 0.6% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $12.4M | 44,417 | 0.6% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $13.2M | 171,080 | 0.7% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $15.3M | 227,747 | 0.8% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $17.0M | 825,243 | 0.9% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $17.7M | 455,099 | 0.9% |
| Inozyme Pharma Inc | COM | 45790W108 | $19.1M | 4,280,308 | 1.0% |
| Establishment Labs Hldgs Inc(ESTA) | COM | G31249108 | $19.5M | 429,244 | 1.0% |